Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer

Lung Cancer

Volumn 39, Issue 2, 2003, Pages 145-149

  Kanazawa, Shigenori ^a   Nomura, Shosaku ^a   Kuwana, Midori ^a   Muramatsu, Mikiko ^a   Yamaguchi, Kazuyuki ^a   Fukuhara, Shirou ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Monocyte derived microparticle; Non small cell lung cancer; Platelet activation markers; sE selectin

Indexed keywords

MARKER; SELECTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; VASCULAR DISEASE;

ANNEXIN A5; ANTIGENS, CD; BLOOD PLATELETS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; E-SELECTIN; FEMALE; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MONOCYTES; PERIPHERAL VASCULAR DISEASES; PLATELET ACTIVATION; TUMOR MARKERS, BIOLOGICAL;

EID: 0037311928     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00441-5     Document Type: Article

References (26)

1. Gordon S.G. Cancer cell procoagulants and their role in malignant disease. Semin. Thromb. Hemost. 18:1992;424-433.
2. Honn K.V., Tang D.G., Chen Y.Q. Platelet and cancer metastasis: more than an epiphenomenon. Semin. Thromb. Hemost. 18:1992;392-415.
3. Dvorak H.F. Thrombosis and cancer. Hum. Pathol. 18:1987;275-284.
4. El-Baruni K., Taylor I., Roath S., Francis J.L. Factor X-activating procoagulant in normal and malignant breast tissue. Hematol. Oncol. 8:1990;323-332.
5. Prydz H., Pettersen K.S. Synthesis of thromboplastin (tissue factor) by endothelial cells. Haemostasis. 18:1988;215-223.
6. Adany R., Kappelmayer J., Berenyi E., Szegedi A., Fabian E., Muszbek L. Factors of the extrinsic pathway of blood coagulation in tumour associated macrophages. Thromb. Haemost. 62:1989;850-855.
7. Koomagi R., Volm M. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int. J. Cancer. 79:1998;19-22.
8. Sawada M., Miyake S., Ohdama S., Matsubara S., Masuda S., Yakumaru K., Yoshizawa Y. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br. J. Cancer. 79:1999;472-477.
9. Semeraro N., Montemurro P., Conese M., et al. Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies. Int. J. Cancer. 45:1990;251-254.
10. Rambaldi A., Alessio G., Casali B., Passerini C.G., Donati M.B., Mantovani A., Semeraro N. Induction of monocyte-macrophage procoagulant activity by transformed cell lines. J. Immunol. 136:1986;3848-3855.
11. Satta N., Toti F., Feugeas O., et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J. Immunol. 153:1994;3245-3255.
12. Mesri M., Altieri D.C. Endothelial cell activation by leukocyte microparticles. J. Immunol. 161:1998;4382-4387.
13. Robinson R.A., Worfolk L., Tracy P.B. Endotoxin enhances the expression of monocyte prothrombinase activity. Blood. 79:1992;406-416.
14. Murakami T., Komiyama Y., Masuda M., et al. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease. Eur. J. Clin. Invest. 26:1996;996-1003.
15. Miyazaki Y., Nomura S., Miyake T., et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 88:1996;3456-3464.
16. Nomura S., Suzuki M., Kido H., et al. Differences between platelet and microparticle glycoprotein IIb/IIIa. Cytometry. 13:1992;621-629.
17. Miyake T., Nomura S., Komiyama Y., et al. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation. Thromb. Haemost. 78:1997;902-909.
18. Yanabu M., Ozaki Y., Nomura S., et al. Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein Ib monoclonal antibody. Blood. 89:1997;1590-1598.
19. Xie G.L., Nomura S., Fukuhara S. Annexin V expression and membrane vesiculation during activation of leukemic cell lines. Haemostasis. 27:1997;259-268.
20. Sims P.J., Faioni E.M., Wiedmer T., Shattil S.J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and expres prothrombinase activity. J. Biol. Chem. 263:1988;18205-18212.
21. Nomura S. Function and clinical significance of platelet-derived microparticles. Int. J. Hematol. 74:2001;397-404.
22. White E.S., Strom S.R., Wys N.L., Arenberg D.A. Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity. J. Immunol. 166:2001;7549-7555.
23. Tschope D., Spangenberg P., Esser J., Schwippert B., Kehrel B., Rosen P., Gries F.A. Flow cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actins status of activated platelets. Cytometry. 11:1990;652-656.
24. Inufusa H., Kojima N., Yasutomi M., Hakomori S. Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimetric Le(x)(defined by Mab FH6) and LCP. Clin. Exp. Metastasis. 9:1991;245-257.
25. Staal-van den Brekel A.J., Thunnissen F.B., Buurman W.A., Wouters E.F. Expression of E-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 in non-small-cell lung carcinoma. Virchows. Arch. 428:1996;21-27.
26. Tsumatori G., Ozeki Y., Takagi K., Ogata T., Tanaka S. Relation between the serum E-selectin level and the survival rate of patients with resected non-small cell lung cancers. Jpn. J. Cancer Res. 90:1999;301-307.